Exosomes are small extracellular vesicles present in various body fluids such as saliva, urine, blood, and breast milk. These vesicles play an important role in intercellular communication processes and have specific composition of proteins, lipids, messenger RNA (mRNA), and micro RNA. Currently, exosomes have great potential to be used as a vehicle for drug delivery and a biomarker for the diagnosis of various diseases and for therapeutic use. Moreover, exosomes offer an alternative pathway for invasive biopsy used in the diagnosis and management of different types of cancer.
The global exosome diagnostic and therapeutic market is expected to reach $367 million by 2022, growing at a CAGR of 37.8% from 2016 to 2022. Increase in prevalence of cancer, growth in initiatives implemented by the government and non-government associations for rise in health awareness play a pivotal role in the growth of the global exosome diagnostic and therapeutic market. Moreover, technological advancements in exosomes isolation, analytical procedures, and innovative and advanced applications of exosomes also supports to the growth of the market. Stringent government regulations for the approval of exosomes diagnostic and therapeutic products and low awareness about the applications of exosomes hamper the market growth.
The world exosomes diagnostic and therapeutic market is segmented based on application, product, end user, and geography. Based on the application, it is divided into diagnostic and therapeutic applications. Based on the product, it is classified into instrument, reagents, and software used in the isolation and analysis of exosomes from cells and tissues. Based on end user, the market is segmented into cancer institute, institutes, hospitals, diagnostic centers, and others (medical universities, and not-for-profit organizations). Geographically, the market is segmented across four major regions, such as North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, and rest of Europe), Asia-Pacific (China, Japan, and rest of Asia-Pacific) and LAMEA.
Key market segments
The world exosome diagnostic and therapeutic market is segmented into application, product, end user, and geography.
MARKET BY APPLICATION
MARKET BY PRODUCT
MARKET BY END USER
MARKET BY GEOGRAPHY
Other players in the value chain include (profiles not included in the report)
The Global Cetirizine Hydrochloride market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Cetirizine Hydrochloride market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses ...
November 2017 | $4660 |View Details>>
In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include UCB Pharma Pfizer J ...
November 2017 | $3360 |View Details>>
In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in ...
November 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research